17.12.2025 | THE FINNISH MEDICAL FOUNDATION
CEO Samu Lehtonen has been nominated for the prestigious Pohjola Medical Innovation Award in recognition of the Marginum team’s scientific contributions.
3.11.2025 | BUSINESS FINLAND
Marginum has been selected for the prestigious Young Innovative Companies (YIC) program, a recognition reserved for Finland’s most promising startups.
20.10.2025 | MARGINUM NEWS
Marginum has completed the HIVEN® usability assessment at the University of Illinois College of Medicine Surgical Innovation and Training Laboratory.
15.10.2025 | Marginum News
Thomy F.E., d.o.o., one of Slovenia’s leading distributors of advanced medical and surgical technologies, has formed a strategic partnership with Marginum.
3.10.2025 | Redacción Médica
MBA SURGICAL EMPOWERMENT, a leading Spanish distributor in the medical-surgical technology sector, has partnered with Marginum.
25.9.2025 | BUSINESS WIRE
Marginum receives MDR certification and releases the first-of-a-kind HIVEN® device, bringing the technology to clinical use in the EU.
22.8.2025 | Talouselämä
Marginum raises €2.5M in Pre-Series A funding to expand HIVEN® into European markets and acquire U.S. FDA clearance.
3.7.2025 | Marginum News
Mediplast AB, a leading distributor of medical devices in the Nordic region, has entered into a strategic collaboration with Marginum.
17.3.2025 | Marginum News
Oslo University Hospital has joined the HIVEN® multicentre trial investigating the clinical performance of the aspirate tissue monitoring method.
15.10.2024 | Marginum News
To date, this is the first patient in the world treated with fluorescence-guided aspirate tissue monitoring technology utilising the Marginum HIVEN® device.